Cancer
US approves lung cancer drug costing 780,000 USD
The US has just licensed the drug tarlatamab-dlle to treat metastatic small cell lung cancer, costing 780,000 USD for one year of treatment.
Tarlatamab Dll
Browse ScienceInfo articles and explainers related to Tarlatamab Dll.
Topic archive
Articles about Tarlatamab Dll
1 published item.